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An important function of immunoreceptor tyrosine-
based activation motif (ITAM)-coupled receptors is
cross-regulation of heterologous receptor signaling,
butmechanisms of cross-inhibition are poorly under-
stood. We show that high-avidity ligation of ITAM-
coupled b2 integrins and FcgRs in macrophages
inhibited type I interferon receptor and Toll-like
receptor (TLR) signaling and induced expression of
interleukin-10 (IL-10); signaling inhibitors SOCS3,
ABIN-3, and A20; and repressors of cytokine gene
transcription STAT3 and Hes1. Induction of inhibitors
was dependent on a pathway composed of signaling
molecules DAP12, Syk, and Pyk2 that coupled to
downstream kinases p38 and MSKs and required
integration of IL-10-dependent and -independent
signals. ITAM-induced inhibitors abrogated TLR
responses by cooperatively targeting distinct steps
in TLR signaling. Inhibitory signalingwas suppressed
by IFN-g and attenuated in inflammatory arthritis
synovial macrophages. These results provide an
indirect mechanism of cross-inhibition of TLRs and
delineate a signaling pathway important for deactiva-
tion of macrophages.
INTRODUCTION
Multiple immune cell receptors signal via an immunoreceptor
tyrosine-based activation motif (ITAM) contained in the receptor
cytoplasmic domain or in an associated ITAM-containing
adaptor (Abram and Lowell, 2007). The major ITAM-containing
adaptors in myeloid cells, DAP12 and FcRg, associate with
and transmit signals from approximately 20 receptors whose
ligands are mostly not known. ITAM-associated myeloid cell
receptors with known ligands include Fc receptors that are
ligated by immunoglobulins and immune complexes and Mincle
that senses necrotic cell and fungal products. Genetic evidence518 Immunity 32, 518–530, April 23, 2010 ª2010 Elsevier Inc.shows that b2 and b3 integrins that engage intercellular adhesion
molecules (ICAMs) and extracellular matrix components signal
via ITAMs, although no direct association of integrins with
ITAM-containing proteins has been reported (Abram and Lowell,
2007; Yamasaki et al., 2008). In addition, several C-type lectin
receptors that sense microbial pathogens or necrotic cells,
such as CLEC7A (also called Dectin-1) and CLEC9A (Sancho
et al., 2009), contain ITAM-like motifs and utilize similar signaling
pathways. Ligation of ITAM-associated receptors results in Src
family kinase-mediated phosphorylation of ITAM tyrosine resi-
dues and, thereby, recruitment and activation of the Syk protein
tyrosine kinase. Syk plays a key role in downstream activation
of NF-kB via the CARD9 adaptor and of protein kinase C
(PKC) and calcium signaling via activation of phospholipase Cg
(PLCg). Both CARD9- and PLCg-dependent pathways con-
tribute to downstream activation of mitogen-activated protein
kinases (MAPKs), and Syk also activates phosphatidylinnosi-
tol-3 kinase (PI3K) and production of reactive oxygen intermedi-
ates (reviewed in Ivashkiv, 2009).
Ligation of ITAM-associated receptors can have enhancing or
inhibitory effects on macrophage activation. One determinant of
the functional outcome of ITAM signaling is the avidity of ITAM-
associated receptor ligation (Hamerman and Lanier, 2006;
Ivashkiv, 2008; Turnbull and Colonna, 2007). High-avidity acute
ligation activates NF-kB and MAPKs that mediate inflammatory
responses, thus explaining the role of ITAM-associated recep-
tors such as FcgRs in cell activation and inflammatory disease
pathogenesis. In contrast, low avidity or tonic ITAM-associated
receptor ligation generates alternative inhibitory signals, such
as activation of the tyrosine phosphatase SHP-1 (Pasquier
et al., 2005), that deactivate macrophages. Consistent with a
suppressive function, ITAM signaling has been implicated in
attenuating cytokine toxicity and in ameliorating inflammatory
conditions such as glomerulonephritis (Hamerman et al., 2005;
Kanamaru et al., 2008; Turnbull and Colonna, 2007). Thus, nega-
tive signaling by ITAMs is important in regulating inflammation
in vivo, and there is substantial interest in therapeutic manipula-
tion of this signaling pathway in inflammatory diseases. Suc-
cessful therapeutic manipulation of ITAM signaling will require
increased understanding of inhibitory signaling mechanisms
activated by ITAM-associated receptors.
Immunity
ITAM Signaling Inhibits TLR and IFN ResponsesIt has become increasingly apparent that an important func-
tion of ITAM-associated receptors is to regulate signaling by
heterologous receptors, including TLRs, tumor necrosis factor
receptors (TNFRs), and cytokine receptors (Ivashkiv, 2008; Kles-
ney-Tait et al., 2006). Thus, one mechanism by which ITAM-
associated receptors suppress macrophage activation is to
inhibit cellular responses to strongly activating receptors such
as TLRs. Previous reports have identified mechanisms of
cross-inhibition whereby ITAM pathway signaling components
directly interact with and suppress TLR signaling molecules.
Mechanisms of direct cross-inhibition include ITAM-mediated
recruitment of phosphatases, activation of PI3K-mediated path-
ways that can suppress NF-kB and MAPK activation, regulation
of recruitment of MyD88 and Mal adaptors to TLRs, regulation of
intracellular trafficking of TLRs, and activation of calcineurin that
can dephosphorylate TLRs and downstream signaling mole-
cules (Fukao and Koyasu, 2003; Ivashkiv, 2008; Kagan and
Medzhitov, 2006; Pasquier et al., 2005; Turnbull and Colonna,
2007). Little is known about indirect mechanisms of cross-inhibi-
tion, which function by inducing de novo expression of inhibitory
proteins. The previously described direct inhibitory mechanisms
are active under conditions of low avidity engagement of ITAM-
associated receptors and tonic ITAM-mediated signaling. For
example, ongoing ligation of DAP12-associated TREM-2 by
constitutively expressed (but unknown) ligands results in cross-
inhibition of TLR responses by an unknown mechanism (Hamer-
man et al., 2005). However, high-avidity and acute cross-linking
of ITAM-associated receptors can also generate inhibitory
effects. For example, extensive crosslinking of Fc receptors
inhibits LPS-induced IL-12 production, and high-avidity anti-
body-mediated crosslinking of the ITAM-associated receptors
ILT7, BDCA-2, Siglec-H, and NKp44 suppresses TLR-induced
type I IFN production in pDCs (Cao et al., 2006; Grazia Cappiello
et al., 2001; Swiecki and Colonna, 2007). Mechanisms and
signaling pathways by which high-avidity ITAM-associated
receptor ligation inhibits TLR responses are mostly unknown.
We previously found that IFN-a-induced Jak-STAT signaling in
macrophages is augmented under steady-state adherent culture
conditions characterized by ongoing low avidity b2 integrin clus-
tering and tonic calcium signaling by ITAM-containing DAP12
(Wang et al., 2008). In the current study, we investigated the
effects of high-avidity and acute ITAM-associated receptor
crosslinking on IFN-a-induced Jak-STAT signaling and on TLR
signaling. We used predominantly primary human monocytes
and macrophages because of their relevance for human inflam-
matory disease pathogenesis; use of these cells also allowed
direct comparison to human disease samples. To ligate ITAM-
associated receptors, we used fibrin(ogen) (Fb) and immune
complexes (ICs), ligands that are highly expressed at inflamma-
tory sites, to strongly and acutely activate signaling by, respec-
tively, b2 integrins and FcgRs on macrophages. Pretreatment
with Fb and ICs strongly and rapidly inhibited signaling by the
type I IFN receptor IFNAR and TLRs. Inhibition of TLR signaling
was mediated by coordinate induction and action of inhibitors
of signaling and cytokine gene transcription. This inhibitory
pathway was suppressed by IFN-g and was abrogated in
joint macrophages from patients with chronic inflammatory
arthritis. These results delineate an inhibitory signaling pathway
important for deactivating macrophages and identify a mecha-nismbywhich high-avidity ligation of ITAM-associated receptors
indirectly inhibits TLR signaling. Suppression of this inhibitory
pathway by IFN-g and in autoimmune diseases may contribute
to increased and chronic inflammatory responses.
RESULTS
High-Avidity b2 Integrin and FcgR Ligation
Cross-inhibits IFN-a and TLR Signaling
We tested the hypothesis, based on current models (Hamerman
and Lanier, 2006; Ivashkiv, 2008; Turnbull and Colonna, 2007),
that high-avidity ligation of ITAM-coupled receptors would result
in a switch in function and, thus, in inhibition of IFN-a-induced
Jak-STAT signaling. We induced acute high-avidity ligation of
ITAM-associated b2 integrins in primary human monocyte-
derived macrophages by plating cells on culture dishes coated
with fibrinogen (Fb); this represents a standard experimental
approach for effectively engaging b2 integrins (Abram and Low-
ell, 2009; Adams et al., 2007). High-avidity ligation of b2 integrins
by preplating macrophages on Fb for 1–16 hr inhibited IFN-a-
induced STAT1 tyrosine phosphorylation (Figure 1A, compare
lanes 4, 6, 8, and 10 to lane 2); IFN-a-induced STAT3 tyrosine
phosphorylation was also suppressed (Figure 1A, lane 4). Inhibi-
tion of IFN-a signaling was functionally important because Fb
suppressed IFN-a-induced gene activation (Figure 1B). Notably,
inhibition of IFN-a responses was induced within 1 hr of integrin
engagement and was sustained for at least 16 hr; this inhibitory
effect on signaling or gene expression has been reproducibly
observed in >20 independent blood donors (data not shown).
No inhibitory effect was observed when macrophages adhered
to plates that had been blocked with FBS, which was used
as a negative control in many experiments (data not shown).
Several approaches, including using MyD88- and Trif-deficient
macrophages and blocking LPS, showed that Fb-mediated
effects were not secondary to contaminating microbial products
(data not shown). These results show that high-avidity b2
integrin ligation by fibrinogen inhibits signaling by a heterologous
receptor, in this case the IFNAR. High-avidity ligation of ITAM-
coupled FcgRs using immune complexes also effectively
inhibited IFN-a signaling, but IFN-g signaling was not affected,
showing specificity of inhibition (data not shown). Thus, at least
two different ITAM-associated receptors inhibit IFN-a signaling
after high-avidity ligation that generates an acute and strong
ITAM-mediated signal in an experimental system that models
acute engagement of integrins and Fc receptors that occurs
whenmigratingmonocytes/macrophages encounter fibrin(ogen)
and immune complexes at inflammatory sites.
Another notable result was that Fb alone (in the absence of
IFN-a) induced strong phosphorylation of STAT3 that became
readily apparent 3 hr after Fb stimulation and was sustained
for at least 16 hr (Figure 1A, lanes 5, 7, and 9). In contrast, Fb-
induced STAT1 phosphorylation was transient and only detected
at the 3 hr time point. STAT3 is a key negative regulator of
myeloid cells and inflammation (Murray, 2007), and thus, the
observed pattern of STAT activation is suggestive of sustained
induction of an inhibitory pathway. One key function of STAT3
is inhibition of cytokine production in myeloid lineage cells,
although STAT3 can also contribute to inflammation by its
actions in other cell types, for example, promoting B cell survivalImmunity 32, 518–530, April 23, 2010 ª2010 Elsevier Inc. 519
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Figure 1. b2 Integrin Ligation by Fb Inhibits IFN-a and TLR Signaling
(A) Immunoblot analysis of whole-cell lysates of primary human macrophages
that were kept suspended (Non-adh) or added to plates coated with fibrinogen
(Fb) for the indicated times and then stimulated with IFN-a (25 ng/ml) for
15 min. Blots were probed with antibodies against tyrosine-phosphorylated
STAT1 (pY-STAT1), tyrosine-phosphorylated STAT3 (pY-STAT3), STAT1,
and STAT3. Data are representative of 15 similar experiments.
(B) Real-time RT-PCR analysis of CXCL9 mRNA from primary human macro-
phages plated on Fb-coated plates for the indicated times and stimulated
with IFN-a (25 ng/ml) for 3 hr. Results are presented as mean ± SD of triplicate
wells normalized relative to GAPDH mRNA and are representative of at least
three experiments.
(C) Real-time RT-PCR analysis of IL-6 and TNF mRNA from primary human
macrophages plated on Fb-coated plates for 1 hr, followed by stimulation
with LPS (10 ng/ml) or Pam3Cys (10 ng/ml) for 3 hr. Results are presented
as mean ± SD of triplicate wells normalized relative to GAPDH mRNA and
are representative of at least three experiments.
See also Figure S1.
Immunity
ITAM Signaling Inhibits TLR and IFN Responsesand differentiation and the differentiation of Th17 cells. Because
of the inhibitory effects of STAT3 on cytokine production in
macrophages, we tested the effects of Fb on TLR-induced cyto-520 Immunity 32, 518–530, April 23, 2010 ª2010 Elsevier Inc.kine expression. Preplating of human macrophages on Fb
rapidly (within 1 hour) and strongly inhibited TLR2- and TLR4-
induced IL-6, TNF, IL-1b, and IL-8 expression (Figure 1C and
data not shown). Strikingly, high-avidity FcgR ligation also sup-
pressed TLR4-induced cytokine gene expression, although to
a lesser extent than the essentially complete inhibition observed
with Fb (Figure S1A available online). Suppression of TLR4-
induced cytokine expression was not observed when cells
were added to plates coated with fetal bovine serum (FBS)
(Figure S1A). Collectively, the results show that high-avidity liga-
tion of two different ITAM-associated receptors, b2 integrins and
FcgRs, in primary human macrophages induces a potent inhibi-
tory pathway that cross-inhibits responses to heterologous
receptors, including IFNAR and TLRs.
Fb- and Immune Complex-induced Expression
of Cytokines and Signaling Inhibitors
We postulated that b2 integrin ligation may induce expression of
cytokines that activate STAT3 and of signaling inhibitors that
cross-regulate IFN-a and TLR pathways; such inhibitors could
also establish a feedback inhibition loop that attenuates integ-
rin-induced activating functions. We explored this idea by
analyzing Fb-induced expression of cytokines and signaling
inhibitors. We found that high-avidity ligation of b2 integrins
using fibrinogen induced rapid but transient expression of
inflammatory cytokine TNF and IL-6 mRNA (Figure 2A). TNF
and IL-6 mRNA amounts peaked approximately 2 hr after integ-
rin ligation and subsequently were strongly downregulated
to return to close to baseline 4 hr after integrin ligation (Fig-
ure 2A). We observed a slower induction of IL-10, a potent
suppressor of cytokine production that activates STAT3 (Fig-
ure 2A). We also observed delayed kinetics of induction (relative
to TNF and IL-6) of known STAT3 target genes that inhibit signal
transduction: SOCS3 (inhibits Jak-STAT signaling and possibly
TLR signaling) (Yoshimura et al., 2007) and ABIN-3 (interacts
with A20 and inhibits NF-kB activation downstream of TNFRs
and TLRs in human cells) (Weaver et al., 2007) (Figure 2A).
Interestingly, Fb also induced expression of inhibitors that are
not known to be STAT3-dependent: Hes1, a transcriptional
repressor that inhibits IL-6 expression (Hu et al., 2008)
(Figure 2A), and A20 that inhibits signaling by several receptors,
including TNFRs and TLRs (Coornaert et al., 2009) (Figure 2B).
Induction of IL-10, SOCS3, Hes1, and A20 proteins was
confirmed by immunoblotting and ELISA (Figures 2B and 2C
and Figure S2). Signaling inhibitors were induced by Fb in
MyD88- and Trif-deficient macrophages and when LPS was
blocked using polymyxin B, indicating that induction was not
secondary to microbial contaminants (data not shown). Stimula-
tion of human macrophages with immune complexes also
induced expression of SOCS3, ABIN-3, Hes1, and A20, albeit
to a lesser extent than did Fb (Figure S1B); this lesser induction
correlated with lesser inhibition of TLR4-induced gene expres-
sion (Figure S1A). In contrast, fibronectin, a ligand for b1 integrins
that does not engage DAP12-mediated signaling pathways, did
not induce expression of inhibitory proteins (Figure S1B), which
correlated with lack of inhibition of TLR-induced IL-6 expression
(Figure S1A). These results suggest that b2 integrin ligation by
Fb, and to a lesser extent FcgR ligation by immune complexes,
induces a potent counter-regulatory loop that feeds back and
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Figure 2. Fb-Induced Expression of Cytokines and
Signaling Inhibitors
(A) Real-time RT-PCR analysis of TNF, IL-6, IL-10, SOCS3,
ABIN-3, and Hes1 mRNA from primary human macro-
phages plated on control FBS-coated or Fb-coated plates
for the indicated times. Results are presented as mean ±
SD of triplicate wells normalized relative to GAPDHmRNA.
(B) Real-time RT-PCR (left panel) and immunoblot analysis
(right panel) of A20 expression in macrophages treated as
in (A). Data are representative of at least three experi-
ments.
(C) ELISA analysis of IL-10 protein in culture supernatants
of macrophages plated on control or Fb-coated plates for
3 hr. Each symbol represents an independent experiment
with different blood donors (n = 16, not all data points are
apparent because of overlap) and the horizontal line indi-
cates the mean; p < 0.01 by paired t test.
See also Figure S2.
Immunity
ITAM Signaling Inhibits TLR and IFN Responsesinhibits integrin- and FcgR-mediated inflammatory cytokine
production and can also cross-inhibit signaling by heterologous
receptors.
IL-10 Contributes to Fb-Mediated Inhibition of TLR
Responses
We then investigated the role of autocrine Fb-induced IL-10
in STAT3 activation; feedback inhibition of cytokine production;
induction of signaling inhibitors SOCS3, ABIN-3, Hes1, and A20;
and cross-regulation of TLR responses. Neutralization of IL-10
and blockade of the IL-10R strongly attenuated Fb-induced
STAT3 tyrosine phosphorylation (Figure 3A), indicating a roleImmunity 32for IL-10 inmediating Fb-induced STAT3 activa-
tion. Consistent with this result, IL-10 blockade
resulted in superinduction of Fb-induced TNF
expression (Figure 3B) and attenuated Fb-
induced inhibition of TLR4 and TLR2 responses
(Figure 3C; Figure S3A; data not shown). These
results demonstrate that IL-10 plays a role
in Fb-induced STAT3 activation and identify
induction of IL-10 as one mechanism by which
b2 integrins cross-inhibit TLR responses.
Fb Activates IL-10-Independent
Inhibitory Pathways and A20 Contributes
to Fb-Mediated Inhibition of TLRs
To test whether Fb-induced IL-10 was sufficient
to induce expression of signaling inhibitors
and mediate Fb-induced suppression of TLR
responses, we performed reconstitution exper-
iments adding exogenous IL-10. First, we found
that exogenous IL-10, added at concentrations
up to 10–20 times higher than the endogenous
IL-10 concentrations induced by Fb, only
weakly induced expression of SOCS3 and
ABIN-3 relative to Fb and did not detectably
induce expression of Hes1 or A20 (Figure 4A).
These results are consistent with a previous
report showing that IL-10 is not sufficient to
strongly induce ABIN-3 expression (Weaveret al., 2007). The greatly diminished induction of signaling inhib-
itors by IL-10 relative to Fb is consistent with the preponderance
of reported evidence indicating that IL-10 is a weak inhibitor of
proximal TLR signaling and instead inhibits gene transcription
(Murray, 2005; Murray, 2007 and references therein). Consistent
with the previous reports, exogenous IL-10 did not detectably
suppress TLR4 signaling in our system (Figure 4B). In contrast,
preplating macrophages on Fb effectively inhibited LPS-induced
phosphorylation of I-kBa, JNK, and ERK (Figure 4B). In addition,
exogenous IL-10 at concentrations comparable to those
induced by Fb did not effectively inhibit LPS-induced cytokine
production (data not shown). Taken together, these results, 518–530, April 23, 2010 ª2010 Elsevier Inc. 521
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Figure 3. Role of IL-10 in Fb-Induced STAT3
Phosphorylation and Inhibition of TLR
Responses
(A–C) Primary humanmacrophageswere added to
Fb-coated plates in the presence or absence of
neutralizing antibodies to IL-10 and IL-10R or
corresponding isotype control antibodies (all at
10 mg/ml) for 3 hr (A and B) or 1 hr followed by
a 3 hr stimulation with LPS (10 ng/ml) (C). (A)
Immunoblot analysis of whole-cell lysates probed
with antibodies against tyrosine-phosphorylated
STAT3 (pY-STAT3) and STAT3. (B and C) Real-
time RT-PCR analysis of TNF and IL-6 mRNA;
results are presented as mean ± SD of triplicate
wells normalized relative to GAPDH mRNA.
Data are representative of at least three indepen-
dent experiments.
See also Figure S3.
Immunity
ITAM Signaling Inhibits TLR and IFN Responsesindicate that IL-10 is not sufficient to mediate the full inhibitory
effects induced by Fb and suggest that Fb can induce inhibitory
pathways independently of IL-10.
To corroborate the idea that Fb induces inhibitory signaling at
least in part independently of IL-10, we tested whether Fb could
induce expression of signaling inhibitors when IL-10 activity was
blocked. IL-10 blockade was effective because it resulted in
increased IL-6production (Figure 4C) but onlypartially attenuated
ABIN-3 and Hes1 expression (Figure 4C); surprisingly, Fb-medi-
ated induction of SOCS3, a classic IL-10-inducible STAT3 target
gene, was only weakly affected by IL-10 blockade (Figure S3B).
Because IL-10 blockade using antibodies may not be complete,
we used IL-10-deficient murine macrophages. The Fb-induced
effects in human macrophages described above were for the
most part reproduced in mouse bone marrow-derived macro-
phages, although the integrin-mediated signal was quantitatively
weaker and more transient (data not shown). Deficiency of IL-10
resulted in a dramatic superinduction of Fb-induced IL-6 expres-
sion but, surprisingly, minimal decrease in SOCS3 expression
(Figure 4D). Finally, Fb-induced A20 expression was actually
increased when IL-10 was deficient (Figure 4D). Together with
data that IL-10 blockade did not reverse Fb-mediated inhibition
of IFN-a signaling (FigureS3C), the results show that the inhibitory
pathway inducedbyFb ismediated in part by IL-10but that IL-10-
independent inhibitory signals are also generated. Consistent
with these results, stimulation of FcgRs by immune complexes
induced expression of SOCS3, ABIN-3, Hes1, and A20, despite
minimal induction of IL-10 expression (Figure S1B). IL-10-inde-
pendent signals were functionally important for cross-inhibition
of signaling because RNAi-mediated knockdown of A20 expres-
sion attenuated Fb-mediated suppression of TLR4-induced IL-6522 Immunity 32, 518–530, April 23, 2010 ª2010 Elsevier Inc.and TNF expression (Figure 4E). These
results support a model whereby TLR4
signaling is inhibited by coordinated
action of Fb-induced signaling inhibitors.
DAP12 and Syk Mediate Inhibitory
Signaling
We took advantage of the murine system
and available gene-targeted mice togenetically define the receptors and upstream signaling compo-
nents that transmit the Fb-induced inhibitory signal to induction
of signaling inhibitor genes. We analyzed bone marrow-derived
macrophages derived from mice with a hypomorphic allele of
Itgb2 that express 10%–15% of wild-type amounts of b2 integrin
(CD18) (termed Itgb2hypo) and from DAP12-deficient mice, and
fetal liver-derived macrophages derived from Syk-deficient fetal
livers. Phenotypic analysis of mutant macrophages revealed
homogeneous and intact expression of macrophage markers
including CD11b, CD68, and F4/80 (data not shown). Fb-induced
expression of IL-10 was attenuated in macrophages from
Itgb2hypo mice (Figure 5A), thus confirming that cells are being
activated via b2 integrins. Investigation of downstream signaling
pathways revealed that deficiency of DAP12 and Syk, key
signaling mediators downstream of b2 integrins, resulted in
decreased Fb-induced IL-10 expression (Figures 5B and 5C).
DAP12andSykdeficiencyalso resulted in decreasedFb-induced
expression of SOCS3 (Figures 5B and 5C), which is independent
of IL-10 (Figure 4D). Fb-induced expression of IL-6wasminimally
affected (Figures 5B and 5C); thus, DAP12 andSykdeficiency did
not globally affect macrophage responses to Fb. Fb-induced
expression of A20 was also diminished in DAP12-deficient
macrophages (Figure 5D). Experiments using Itgb2hypo and
DAP12-deficient mice confirmed that expression of IL-10,
SOCS3, and A20 was partially dependent on b2 integrins and
DAP12 in vivo (Figure 5E). We obtained similar confirmatory
results implicating b2 integrins and Syk in inhibitory signaling in
human macrophages using CD18 blocking antibodies or picea-
tannol to inhibit Syk (Figure S4). Collectively, these results
strongly implicate a b2 integrin-DAP12-Syk pathway in the induc-
tionof IL-10,SOCS3,andA20expressionand inhibitory signaling.
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Figure 4. Fb Induces Inhibitory Signals
Independently of IL-10, and Fb-Induced
A20 Contributes to Inhibition of TLRs
(A) Real-time RT-PCR analysis of SOCS3, ABIN-3,
Hes1, and A20mRNA from primary humanmacro-
phages added to Fb-coated plates or stimulated
with the indicated concentrations of IL-10 for
3 hr. Results are presented as mean ± SD of tripli-
cate wells normalized relative to GAPDH mRNA.
(B) Immunoblot analysis of primary human macro-
phages preplated on Fb-coated plates or preincu-
bated with IL-10 (2 ng/ml) for 3 hr, followed by
stimulation with LPS (10 ng/ml) for the indicated
times.
(C) Real-time RT-PCR analysis of IL-6, Hes1, and
ABIN-3 mRNA from primary human macrophages
that were added to Fb-coated plates in the pres-
ence or absence of neutralizing antibodies to
IL-10 and IL-10R or corresponding isotype control
antibodies (all at 10 mg/ml) for 3 hr. Results are pre-
sented as mean ± SD of triplicate wells normalized
relative to GAPDH mRNA.
(D) Real-time RT-PCR analysis of IL-6, SOCS3,
and A20 mRNA from BMDMs from genetically
matched control or IL-10-deficient mice that
were added to Fb-coated plates for indicated
times.
(E) Left panel: real-time RT-PCR analysis of IL-6
and TNF mRNA normalized relative to GAPDH
mRNA from primary human monocytes that were
nucleofected with control or A20-specific short
interfering RNAs (siRNAs) and, 2 days later, added
to Fb-coated plates for 1 hr, followed by stimula-
tion with LPS (10 ng/ml) for 3 hr. Right panel:
immunoblot analysis of whole-cell lysates of
macrophages that were nucleofected with control
or A20-specific siRNA.
Data are representative of two (A and B) or at least
three independent experiments (C–E).
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ITAM Signaling Inhibits TLR and IFN ResponsesCalcium Pathways Induce Signaling Inhibitors via p38
and MSKs
DAP12 and Syk activate calcium signaling pathways, and we
have proposed a role for calcium signaling inmediating crosstalk
between ITAM-associated and heterologous receptors (Ivash-
kiv, 2009). Thus, we tested the role of calcium pathways in
induction of signaling inhibitors by Fb. Chelation of calcium
using BAPTA or inhibition of calmodulin using W-7 suppressed
Fb-mediated induction of IL-10, SOCS3, and A20 expression
(Figure 6A). To establish a molecular link between calcium
signaling and downstream activation of signaling inhibitors, weImmunity 32, 518–5tested the role of Pyk2, a calcium-depen-
dent protein tyrosine kinase that trans-
mits calcium signals to downstream
activation of MAPKs, such as p38, that
have been implicated in induction of
IL-10, SOCS3, and A20 expression (Avra-
ham et al., 2000; Bode et al., 1999; Hu
et al., 2006). Plating of human macro-
phages on Fb induced tyrosine phos-
phorylation and thus activation of Pyk2
with delayed kinetics that correlatedwith IL-10 expression (Figure 6B). Activation of Pyk2 in our
system was dependent on calcium because it was abolished
by the calcium chelator BAPTA and the calmodulin inhibitor
W7 (Figure 6C). Pyk2 activation was also suppressed by the
Src inhibitor PP2 (Figure 6C); Src kinases can activate Pyk2 via
ITAM-calcium signaling or by direct interaction and phosphory-
lation. Downregulation of Pyk2 expression using RNA interfer-
ence or inhibition of Pyk2 using a chemical inhibitor AG17
resulted in diminished Fb-induced activation of STAT3 (Figures
6D and 6E). In addition, RNAi-mediated targeting of Pyk2
mRNA or inhibition by AG17 resulted in decreased IL-1030, April 23, 2010 ª2010 Elsevier Inc. 523
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Figure 5. b2 Integrins, DAP12, and Syk
Mediate Inhibitory Signaling
(A–D) Real-time PCR analysis of IL-10, SOCS3,
IL-6, and A20 mRNA from BMDMs from geneti-
cally matched control, Itgb2hypo, or DAP12-defi-
cient mice (A, B, and D) or from control or Syk-
deficient fetal liver-derived macrophages derived
from fetuses from the same pregnancy (C). Macro-
phages were added to Fb-coated plates for
the indicated times. Results are presented as
mean ± SD of triplicate wells normalized relative
to GAPDHmRNA and are representative of at least
two experiments.
(E) ELISA of serum IL-10 protein and real-time RT-
PCR analysis of splenic SOCS3 and A20 mRNA
from genetically matched 8-week-old control
(WT), Itgb2hypo, and DAP12-deficient male mice
that had been injected IP with LPS (5 mg/kg)
1.5 hr previously. mRNA results were normalized
relative toGAPDHmRNA, and results for individual
mice are depicted relative to control mice that had
not been injected with LPS (set at 1). Representa-
tive results from two independent experiments
with a total of five mice per genotype are shown;
each symbol corresponds to one mouse.
See also Figure S4.
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ITAM Signaling Inhibits TLR and IFN Responsesproduction and decreased expression of SOCS3 (Figure 6F and
Figure S5). These results indicate that Fb-induced inhibitory
signaling is transduced at least in part by calcium-mediated
signals and Pyk2, although signals that are independent of
Pyk2 could complement Pyk2 signals.
Pyk2 plays a role in the activation of MAPKs, andMAPKs have
been implicated in the induction of IL-10, SOCS3, and A20 in
other systems (Ananieva et al., 2008; Bode et al., 1999; Hu
et al., 2006; Kim et al., 2008). Thus, we tested the role of MAPKs
in transmitting Fb-induced calcium signals to induction of IL-10,
SOCS3, and A20 expression. We found that Fb activated p38
with delayed kinetics that correlated with Pyk2 activation and
shortly preceded IL-10 expression (Figure 6G), and p38 activa-
tion was dependent on calcium (Figure 6C) and on Pyk2
(Figure 6H). This suggested a role for p38 in downstream gene
activation. We next tested the effects of inhibiting p38 on
Fb-induced activation of STAT3 and expression of signaling
inhibitors. Inhibition of p38 using SB203580 strongly suppressed
Fb-induced STAT3 tyrosine phosphorylation (Figure 6I) and
inhibited induction of IL-10, SOCS3, ABIN-3, Hes1, and A20
mRNA (Figure 6J). A role for p38a in induction of inhibitory mole-
cules was confirmed using p38a-deficient macrophages (data524 Immunity 32, 518–530, April 23, 2010 ª2010 Elsevier Inc.not shown). Inhibition of ERK or JNK had
a much smaller suppressive effect on
expression of signaling inhibitors (data
not shown), whereas inhibition of PKC
using GF109203X, used here as a nega-
tive control, had no discernable effects
(Figure 6J). Recent reports have demon-
strated that paradoxical anti-inflamma-
tory actions of p38 are mediated by
downstream MSKs, in part by inducing
IL-10 and DUSP1 expression (Ananievaet al., 2008; Kim et al., 2008). Thus, we tested the role of MSKs
in Fb-induced expression of signaling inhibitors. Fb-induced
expression of IL-10, SOCS3, and A20 was markedly attenuated,
while IL-6 expression was preserved, in macrophages doubly
deficient in MSK1 and MSK2 (Figure 6K). These results demon-
strate that Fb-induced calcium signaling pathways couple to the
p38-MSK pathway to induce expression of signaling inhibitors
and extend the anti-inflammatory functions of MSKs to the
induction of SOCS3 and A20.
Abrogation of Inhibitory Signaling by IFN-g and In Vivo
in Arthritic Macrophages
Our findings suggested a more dominantly suppressive function
for b2 integrins and ITAM-mediated signaling than previously
appreciated (Abram and Lowell, 2009; Adams et al., 2007;
Nimmerjahn and Ravetch, 2008). We reasoned that b2 integrin-
induced inhibitory pathways may function strongly under
homeostatic conditions, but may be regulated in inflammatory
settings to prevent inappropriate or excessive suppression of
immune responses. We first tested this notion by analyzing the
effects of the potent macrophage activating cytokine IFN-g on
Fb-induced b2 integrin-mediated responses. Strikingly, IFN-g
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Figure 6. A Calcium-Dependent Pyk2-p38-MSK Pathway Mediates Fb-Induced Inhibitory Signaling
(A) Real-time RT-PCR analysis of IL-10, SOCS3, and A20mRNA from primary humanmacrophages treated with DMSO (vehicle control), calcium chelator BAPTA
(40 mM), or calmodulin inhibitor W7 (40 mM) and added to Fb-coated plates for 3 hr. Results are presented as mean ± SD of triplicate wells normalized relative to
GAPDH mRNA.
(B–I) Immunoblot analysis of primary humanmacrophages; cells were nucleofected with control or Pyk2-specific siRNA (D) or treatedwith the Pyk2 inhibitor AG17
(10 mM), the p38 inhibitor SB203580 (20 mM) (E, I, and H), the Src kinase inhibitor PP2, or control PP3 (40 mM) and added to Fb-coated plates for 3 hr or the indi-
cated times. Blots were probed with antibodies against tyrosine phosphorylated Pyk2 (p-Pyk2), Pyk2, p38, phosphorylated p38, tyrosine-phosphorylated STAT3
(pY-STAT3), STAT3, and b-tubulin. (F) ELISA analysis of IL-10 protein in culture supernatants. Primary human macrophages were nucleofected with control or
Pyk2-specific siRNA and added to control or Fb-coated plates for 3 hr. Cumulative results from three independent experiments are shown, and IL-10 production
in control siRNA-nucleofected cells is set at 100% for each donor; p < 0.01 by paired Student’s t test.
(J) Real-time PCR analysis of mRNA from humanmacrophages treated with SB203580 (20 mM) or the PKC inhibitor GF109203X (10 mM) and then treated as in (A).
(K) Real-time RT-PCR analysis of IL-10, SOCS3, A20, and IL-6 mRNA from genetically matched control and MSK1-MSK2 doubly deficient mouse BMDMs that
were added to Fb-coated plates for the indicated times. Results are presented as mean ± SD of triplicate wells normalized relative to GAPDH mRNA.
Data are representative of three (A–J) or two (K) independent experiments.
See also Figure S5.
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Figure 7. Abrogation of Fibrinogen-Induced
Inhibitory Signaling by IFN-g and In Vivo in
Arthritic Macrophages
(A) Real-time RT-PCR analysis of IL-10 and
SOCS3 mRNA from primary human macrophages
that had been cultured in the presence or absence
of IFN-g (100 U/ml) for 2 days and then added to
Fb-coated plates for the indicated times. Results
are presented as mean ± SD of triplicate wells
normalized relative to GAPDH mRNA and are
representative of five experiments.
(B) ELISA analysis of IL-10, TNF, and IL-6 protein
from culture supernatants of control monocyte-
derived human macrophages or inflammatory
arthritic macrophages that were cultured for 3 hr
on plates that had been coated with FBS (control)
or Fb. Cumulative data from experiments with
a total of ten control and eight arthritic samples
are depicted; p values were calculated using the
Student’s t test.
(C) Immunoblot analysis of whole-cell lysates from
control or arthritic macrophages treated as in (B).
Data are representative of five independent exper-
iments with different donors.
See also Figure S6.
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ITAM Signaling Inhibits TLR and IFN Responsesstrongly suppressed Fb-mediated induction of IL-10, SOCS3,
ABIN-3, and A20 (Figure 7A and data not shown). These results
suggest that inhibitory signalingbyb2 integrins canbeattenuated
in an inflammatory environment where IFN-g and STAT1 are
active. We then tested whether Fb-induced inhibitory signaling
was attenuated in vivo by testing macrophages freshly isolated
from joints of patients with chronic inflammatory arthritis, such
as rheumatoid arthritis, which show evidence of activation by
IFN-g in vivo and express a ‘‘STAT1 signature’’ (Ivashkiv and Hu,
2003). Interestingly, Fb-mediated induction of IL-10 was attenu-
ated in arthritic macrophages (n = 8, p = 0.0016) (Figure 7B).
Consistent with decreased IL-10 production, Fb-induced
STAT3 activation was diminished in arthritic macrophages
(Figure 7C). In contrast, Fb induced comparable amounts of
TNF in control and arthritic macrophages, and there was a trend
toward increased IL-6 production in arthritic macrophages,
showing that b2 integrins on these cells are functional and that
arthritic macrophage responses to Fb are not globally sup-
pressed (Figure7B). Asa control, IFN-g-inducedphosphorylation
of STAT1 and STAT3 was intact in arthritic macrophages, and
thesecells expressedCD11bandCD18 (FigureS6). Fb-mediated
activationofSTAT3was intact in synovial fluidmacrophages from
acute crystal-induced arthritis (n = 4) (data not shown), suggest-
ing differences in macrophage responses to Fb in acute and
chronic inflammatory diseases. These results demonstrate atten-
uation of the homeostatic effects of fibrinogen and b2 integrin
signaling in a human chronic inflammatory disease; such attenu-
ationmay contribute to themaintenance of chronic inflammation.526 Immunity 32, 518–530, April 23, 2010 ª2010 Elsevier Inc.DISCUSSION
A role for ITAM-associated receptors in
suppressing myeloid cell activation has
become well established, as has the
concept that this suppression occurs viacross-inhibition of activating receptors such as TLRs. Several
mechanisms of direct cross-inhibition have been described,
but signaling pathways that mediate cross-inhibition are not
known and indirect cross-inhibition mediated by induction of
inhibitory proteins has not been previously investigated. In this
study, we have demonstrated that calcium signaling pathways
mediate inhibitory signaling downstream of ITAM-associated
receptors by an indirect mechanism that involves coordinated
induction of inhibitors of signaling and gene expression.
A DAP12-Syk-calcium-Pyk2 pathway induced IL-10, STAT3,
SOCS3, ABIN-3, Hes1, and A20, inhibitors that function in an
integrated manner to strongly suppress TLR signaling, and
have the capacity to cross-inhibit signaling by various activating
receptors that utilize TRAF6 (inhibited by A20), NF-kB (inhibited
by ABIN-3), or Jaks (inhibited by SOCS3) and to inhibit transcrip-
tion of inflammatory cytokine genes (inhibited by Hes1 and
STAT3). Inhibitory signaling was activated by b2 integrins and
FcgRs that are ligated by factors expressed at sites of acute
and chronic inflammation, namely fibrin, complement split prod-
ucts, and immune complexes. Thus, we have identified an inhib-
itory pathway that has the potential to cross-inhibit various
macrophage-activating receptors and to play an important role
in regulation of cytokine production and inflammation.
An important aspect of ITAM-induced cross-inhibition in our
system is the coordinated induction of inhibitory molecules
that can act in an integratedmanner to deactivate macrophages.
This coordinated induction and function of inhibitory molecules
is reminiscent of the induction of T cell anergy by ligation of the
Immunity
ITAM Signaling Inhibits TLR and IFN ResponsesTCR, which is also mediated by ITAM and calcium signaling.
T cell anergy takes several days to become established and
results from calcium-mediated activation of the transcription
factor NFAT, which induces expression of multiple molecules
that suppress signaling by T cell-activating receptors, including
the E3 ligases Cbl-b, Itch, and GRAIL, and also GADD45b,
DAG kinase a, and Deltex1 (Borde et al., 2006; Hsiao et al.,
2009). In contrast, in macrophages, cross-inhibition of activating
receptors was established rapidly, within 1–3 hr of ligation of
ITAM-associated receptors, and was mediated by an alternative
calcium-dependent Pyk2-p38 pathway. One key event down-
stream of Pyk2 and p38 was induction of IL-10, leading to the
activation of STAT3 and inhibition of cytokine gene transcription.
In addition, b2 integrin ligation suppressed TLR4 signaling at
a proximal step, likely via IL-10-independent induction of A20,
which targets proximal TLR4-induced signaling pathways and
inhibits downstream activation of both NF-kB and MAPKs.
IL-10 synergized with an IL-10-independent pathway down-
stream of b2 integrins to induce expression of ABIN-3, Hes1,
and (in human cells) SOCS3, all of which can suppress inflamma-
tory responses. We have provided evidence supporting a role for
IL-10 and A20 in mediating Fb-induced suppression of TLR4
responses, but it is likely that the integrated function of various
Fb-induced signaling inhibitors explains the striking and nearly
complete inhibition of TLR responses that was observed.
Our findings highlight the importance of calcium signaling in
cross-regulation of heterologous receptors by ITAM-associated
receptors. Engagement of calcium signaling pathways leading
to delayed but sustained activation of p38 and MSKs and induc-
tion of multiple signaling inhibitors provides a mechanism by
which high-avidity engagement of ITAM-associated receptors
cross-inhibits TLR signaling. This calcium signaling pathway
confers a capacity for strong inhibitory signaling that distin-
guishes ITAM-associated receptors from more strongly acti-
vating receptors such as TLRs that activate p38 rapidly but
transiently. Thus, although TLRs can transiently activate expres-
sion of the inhibitory effectors induced by Fb as part of feedback
inhibition, on balance, TLRs induce a more proinflammatory
response and Fb induces a more sustained and dominant
suppressive signal. It is tempting to speculate that differences
in the kinetics and amplitude of p38 activation may help explain
the different balance between activating and suppressive
signaling by different receptors.
Genetic, biochemical, and pharmacological evidence estab-
lished that the DAP12-Syk-dependent pathway downstream of
b2 integrins was necessary for inhibitory signaling. FcgRs acti-
vate a similar FcRg-Syk signaling pathway and induced a similar,
but quantitatively weaker, pattern of inhibitory molecule expres-
sion. The weak induction of IL-10 by FcgRs is consistent with
previous work with murine macrophages (Lucas et al., 2005). It
is currently not possible to test the inhibitory potency of addi-
tional ITAM-associated receptors in myeloid cells because their
ligands are not known. One potential explanation for the quanti-
tative difference between b2 integrin and FcgR responses is that
b2 integrin cytoplasmic tails activate signals in addition to ITAM-
dependent signaling (Abram and Lowell, 2009). Such additional
signals include remodeling of the actin cytoskeleton associated
with cell attachment or spreading and the formation of adhesion
structures. Such cytoskeletal remodeling can promote sustainedsignaling (Nguyen et al., 2008) and lead to stronger and more
sustained activation of downstream signaling molecules such
as was observed with Pyk2, which has been previously shown
to be activated in a sustained manner by integrin ligation in other
systems (Abram and Lowell, 2009; Avraham et al., 2000). We
provided evidence that Pyk2 activation was dependent on
calcium, but it is possible that other pathways contribute to
Pyk2 activation. Pyk2 activates downstream MAPK signaling,
leading to induction of signaling inhibitors, as shown in this
study, and can also modulate additional signaling pathways,
such as those mediated by Jaks (Wang et al., 2008) and b-cate-
nin (Otero et al., 2009). Thus, Pyk2 appears to play a prominent
role in signal transduction crosstalk. However, activation of
Pyk2 appears not to be sufficient for downstream induction of
signaling inhibitors, as ligation of b1 integrins by fibronectin,
which also activates Pyk2, was ineffective in inducing expression
of these molecules. Thus, other signaling effectors downstream
of ITAMs or calcium may complement Pyk2 signals. It is likely
that effective induction of signaling inhibitors and cross-inhibi-
tion of TLR responses requires cooperation of ITAM-dependent
and independent pathways, both of which are activated by b2
integrins.
Our findings establish that preligation of b2 integrins or FcgRs
rapidly inhibited TLR signaling. Such preligation of ITAM-associ-
ated receptors occurs as monocytes exit the circulation and b2
integrins engage counterreceptors on endothelial cells and as
macrophages encounter fibrin and complement split products
and immune complexes as they enter an inflammatory micro-
environment. Alternatively, coengagement of ITAM-associated
receptors with TLRs can result in synergistic induction of inflam-
matory cytokine production, at least in the short term. For
example, coengagement of DAP12-associated receptors and
TLRs or of Dectin-1 and TLR2 by yeasts and zymosan results
in increased inflammatory cytokine and IL-23 production (Brown
et al., 2003; Dennehy et al., 2008; Gantner et al., 2003;
LeibundGut-Landmann et al., 2007; Manicassamy et al., 2009;
Turnbull et al., 2005). However, even under conditions of simul-
taneous engagement of ITAM-associated receptors and TLRs,
there is increased IL-10 production (Dennehy et al., 2008; Lei-
bundGut-Landmann et al., 2007), indicating more effective
induction of feedback inhibitory loops whose suppressive
effects will become apparent at later time points than are typi-
cally analyzed in most studies. It will be interesting to test if
simultaneous engagement of ITAM-associated receptors and
TLRs also leads to increased and more sustained expression
of SOCS3, ABIN-3, Hes1, and A20 than that induced by TLRs
alone. Overall, our findings and previous reports support
a dynamic crosstalk between ITAM-associated receptors and
TLRs whose outcome is at least in part dependent on timing of
receptor ligation. During chronic inflammation, the timing and
avidity of engagement of ITAM-associated receptors versus
more strongly activating receptors will vary depending on
disease activity and cell localization and thus, ITAM-associated
receptors have the potential to either augment or suppress
inflammation.
Although inhibitory functions for ITAM-associated receptors
and b2 integrins have been previously described, our findings
demonstrate the potential for stronger and more dominantly
suppressive functions than previously appreciated. Indeed, theImmunity 32, 518–530, April 23, 2010 ª2010 Elsevier Inc. 527
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ITAM Signaling Inhibits TLR and IFN Responsescurrent paradigm is that the ligands used to elicit inhibitory
signaling in this study, fibrin(ogen) and immune complexes,
and their cognate receptors b2 integrins and FcgRs, are strong
activators of inflammation and contributors to the pathogenesis
of inflammatory diseases in murine models (Nimmerjahn and
Ravetch, 2008). One reason that the inhibitory functions of these
ITAM-associated receptors have not been previously fully
appreciated is that b2 integrins and Fc receptors have mostly
activating functions in neutrophils and mast cells, which
predominate in the earliest phases of host defense and in rela-
tively acute mouse models of chronic human diseases. Thus,
gene deletion of b2 integrins or FcgRs may not reveal the
suppressive effects of these receptors because their absence
abolishes the initial activation phase of inflammation, oftenmedi-
ated by neutrophils or mast cells. In the absence of induction of
an inflammatory response in the first place it is not possible to
detect the suppressive functions of these receptors. However,
emerging evidence supports suppressive functions for b2 integ-
rins (especially aMb2, themain b2 integrin receptor for fibrinogen
that is also called complement receptor 3) and FcgRs in macro-
phages and DCs in cell-based functional assays and in select
in vivo models. These receptors have been implicated in clear-
ance of immune complexes, suppression of APC function of
DCs, induction of IL-10 expression, and phagocytosis of
apoptotic cells (which generates suppressive signals) (Behrens
et al., 2007; Mevorach et al., 1998; Skoberne et al., 2006 and
references therein). Consistent with these in vitro studies,
aMb2 has been shown to suppress TLR-induced cytokine
production in vivo, mediate UV-induced immunosuppression
in the skin, mediate tolerance induction in the eye, suppress
colitis and dermatitis, and attenuate SLE in the MRL/lpr model
(Hammerberg et al., 1998; Leon et al., 2006; Sohn et al., 2003
and references therein). Fc receptors also exert suppressive
functions in vivo, including mediating suppression of IFN-g
responses, innate immune responses against Listeriamonocyto-
genes and Leishmania, LPS toxicity, and glomerulonephritis
(Gerber and Mosser, 2001; Kanamaru et al., 2008; Nimmerjahn
andRavetch, 2008; Park-Min et al., 2007 and references therein).
The suppressive effects of b2 integrins and FcgRs in vivo have
been previously linked to production of IL-10, but underlying
mechanisms were not known. Our findings have provided a
detailed signaling pathway that leads to IL-10 expression and
reveal additional molecular mechanisms by which b2 integrins
and FcgRs can inhibit inflammation.
A second reason why ITAM-mediated inhibitory signaling may
not be readily apparent in certain contexts is that ITAM-induced
inhibitory pathways are subject to regulation that modulates the
balance between pro- and anti-inflammatory ITAM effects. This
notion is supported by our data that IFN-g suppresses inhibitory
signaling downstream of b2 integrins. In this scenario, inhibitory
signaling is appropriately suppressed during an active immune
response characterized by IFN-g production. Then, as the infec-
tion is cleared, inhibitory signaling and suppressive functions
of ITAM-associated receptors would emerge and participate in
the resolution phase of inflammation. Alternatively, our results
suggest that in pathological settings, such as chronic human
autoimmune diseases characterized by ongoing IFN-g-STAT1
activity, the inhibitory and homeostatic functions of ITAM-associ-
ated receptors are attenuated. This (inappropriate) suppression528 Immunity 32, 518–530, April 23, 2010 ª2010 Elsevier Inc.of ITAM-induced inhibitory signaling in chronic inflammatory
diseases cancontribute topathogenesis andchronicity of inflam-
mation. Augmentation of signaling by ITAM-mediated inhibitory
pathways may represent an effective new therapeutic approach
to control inflammation in diseases like rheumatoid arthritis.
EXPERIMENTAL PROCEDURES
Cell Culture, Mice, and Reagents
Peripheral blood mononuclear cells (PBMC) were obtained from blood leuko-
cyte preparations purchased from the New York Blood Center by density
gradient centrifugation with Ficoll (Invitrogen, Carlsbad, CA, USA) using
a protocol approved by the Hospital for Special Surgery Institutional Review
Board. Human monocytes were purified from PBMCs immediately after isola-
tion by positive selection with anti-CD14 magnetic beads, as recommended
by the manufacturer (Miltenyi Biotec, Auburn, CA, USA), and cultured in
RPMI-1640 medium (Invitrogen) supplemented with 10% FBS (Hyclone,
Waltham, MA, USA) and M-CSF (10 ng/ml). Monocyte-derived macrophages
obtained after 2 days of culture with human M-CSF were used unless
otherwise noted in figure legends, and purity of monocytes/macrophages
was >97%, as verified by flow cytometric analysis. For stimulation with Fb,
macrophages were harvested and added to plates that had been coated
with Fb (Sigma Aldrich, St. Louis, MO, USA) by incubation overnight with Fb
(100 mg/ml in PBS) followed by PBS washes. Inflammatory arthritis macro-
phages were purified using anti-CD14magnetic beads from pre-existing syno-
vial fluids that had been obtained during the course of standard clinical care
from patients with inflammatory arthritis using a protocol approved by the
Hospital for Special Surgery Institutional Review Board. Experiments with
animals were approved by the Hospital for Special Surgery Animal Care and
Use Committee. DAP12-deficient (Wang et al., 2008), MSK1/MSK2-deficient
(Ananieva et al., 2008), and myeloid lineage p38a-deficient (Kang et al.,
2008) mice have been previously described. Heterozygous Syk-deficient
mice were from V. Tybulewicz (National Institute for Medical Research,
London, UK), and C57BL/6, IL-10-deficient, and Itgb2hypo mice were
purchased from Jackson Laboratories, Bar Harbor, ME, USA. Murine BMDMs
were obtained by culturing BM cells for 5 days on Petri dishes (Midwest Scien-
tific, St. Louis, MO, USA) with mouse M-CSF (10 ng/ml; Peprotech, Rocky Hill,
NJ, USA). Syk-deficient macrophages were obtained using cultures of fetal
liver cells as previously described (Wang et al., 2008). Recombinant human
IFN-aA was from Biosource International (Camarillo, CA, USA), M-CSF was
from PeproTech, and LPS and Pam3Cys were from Invivogen (San Diego,
CA, USA). BAPTA, W-7, AG17, GF109203X, SB203580, and MG-132 were
from CalBiochem (San Diego, CA, USA). ELISA was performed using paired
antibodies (Clone numbers JES3-19F1, JES3-12G8, MQ2-13A5, MQ2-39C3,
MAb1, Mab11) or kits (Catalog numbers 55252, 555240, 555268) purchased
from BD Biosciences (San Jose, CA, USA) following the instructions of the
manufacturer.
Immunoblotting
Whole-cell extracts were obtained, and protein amounts quantitated with the
Bradford assay (BioRad, Hercules, CA, USA). For immunoblotting, cell lysates
(10 mg) were fractionated on 7.5% or 10% polyacrylamide gels using SDS-
PAGE. Monoclonal antibodies (mAbs) to STAT1 (clone 1), and STAT3 (clone
84) were from BD Transduction Laboratories (Lexington, KY, USA); Pyk2
(N-19), Hes1 (H-140), and TBP (N-12) antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Antibodies specific for pY-STAT1
(Y701) (catalog number 9171), pY-STAT3 (Y705) (number 9131), pY-Pyk2
(Y402) (number 3291), A20/TNFAIP3 (number 4625), pIkBa (S32) (number
2859), pERK(T202/Y204) (number 9101), pJNK(T183/Y185) (number 9251),
and SOCS3 (number 2923) were from Cell Signaling Technology (Danvers,
MA, USA).
Gene Expression Analysis
Real-time quantitative PCR was performed using triplicate wells and the
iCycler iQ real-time PCR detection system (Bio-Rad) as previously described.
Oligonucleotide primers were as follows: human SOCS3: 50- CACTCTTCAG
CATCTCTGTCGGAAG-30 and 50-CATAGGAGTCCAGGTGGCCGTTGAC-30;
Immunity
ITAM Signaling Inhibits TLR and IFN Responseshuman CXCL9: 50-ATCAGCACCAACCAAGGGACT-30 and 50-GCTTTTTCTT
TTGGCTGACCTG-30; human GAPDH: 50-ATCAAGAAGGTGGTGAAGCA-30
and 50- GTCGCTGTTGAAGTCAGAGGA-30; human IL-10: 50-TTATCTTGTC
TCTGGGCTTGG-30 and 50-GTTGGGGAATGAGGTTAGGG-30; human A20:
50- CCGGCTGCGTGTATTTTGGGACTC-30 and 50-GGAACCTGGACGCTGTG
GGACTGA-30; human ABIN-3: 50-GTGCCTGGTCATGTTTTCCT-30 and 50-CA
TCCATCTGCCAAGTCTCA-30; human HES1: 50-CAG GCT GGA GAG GCG
GCT AAG GTG-30 and 50-GGA GGT GCC GCT GTT GCT GGT GTA-30; human
IL-6: 50- TAATGGGCATTCCTTCTTCT-30 and 50-TGTCCTAACGCTCATACT
TTT-30; human TNFa: 50- AATAGGCTGTTCCCATGTAGC-30 and 50-AGAGG
CTCAGCAATGAGTGA-30; mouse GAPDH: 50- ATCAAGAAGGTGGTGAAG
CA-30 and 50-AGACAACCTGGTCCTCAGTGT-30; mouse IL-10: 50- CTTTGC
TATGGTGTCCTTTCA-30 and 50-AAGACCCATGAGTTTCTTCAC-30; mouse
SOCS3: 50- GTTTACAATTTGCCTCAATCA-30 and 50-TTCAAGCATCTTCAGA
CAGC-30; mouse A20: 50- GACCACGGCACGACTCACCTG-30 and 50-GATC
GCTGTTCTCCTGCCATTTCT-30; mouse IL-6: 50- AGGCATAACGCACTAGG
TTT-30 and 50-AGCTGGAGTCACAGAAGGAG-30; mouse TNFa: 50- GTCAGG
TTGCCTCTGTCTCA-30 and 50-TCAGGGAAGAGTCTGGAAAG-30 .
RNA Interference
Primary human monocytes were nucleofected immediately after isolation with
150 pmol of siRNA oligonucleotides (DHARMACON, Inc., Chicago, IL, and
Invitrogen) using the Human Monocyte Nucleofector Kit and the AMAXA
Nucleofector System according to the manufacturer’s instructions. Cells
were harvested 2 or 4 days after nucleofection.
SUPPLEMENTAL INFORMATION
The Supplemental Information includes six figures and can be found with this
article online at doi:10.1016/j.immuni.2010.03.014.
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